Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Improvement of drug efficacy of polo-like kinase 4 inhibitor in the treatment of uterine leiomyosarcoma Proceeding/Conference:Cancer Research | 2020 | 51 | ||
PLK4 inhibitor suppresses hepatocellular carcinoma (HCC) through inducing extensive polyploidy and activating STING pathway Proceeding/Conference:EMBO Workshop: Cell death in immunity and inflammation | 2019 | 38 |